199 related articles for article (PubMed ID: 30165040)
21. Simultaneous binding of two peptidyl ligands by a SRC homology 2 domain.
Zhang Y; Zhang J; Yuan C; Hard RL; Park IH; Li C; Bell C; Pei D
Biochemistry; 2011 Sep; 50(35):7637-46. PubMed ID: 21800896
[TBL] [Abstract][Full Text] [Related]
22. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
23. NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site.
Weber T; Schaffhausen B; Liu Y; Günther UL
Biochemistry; 2000 Dec; 39(51):15860-9. PubMed ID: 11123912
[TBL] [Abstract][Full Text] [Related]
24. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
25. Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.
Xu RX; Word JM; Davis DG; Rink MJ; Willard DH; Gampe RT
Biochemistry; 1995 Feb; 34(7):2107-21. PubMed ID: 7532003
[TBL] [Abstract][Full Text] [Related]
26. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
Kristensen SM; Siegal G; Sankar A; Driscoll PC
J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
[TBL] [Abstract][Full Text] [Related]
27. SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading.
Prasad N; Topping RS; Decker SJ
Mol Cell Biol; 2001 Feb; 21(4):1416-28. PubMed ID: 11158326
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.
Folmer RH; Geschwindner S; Xue Y
Biochemistry; 2002 Dec; 41(48):14176-84. PubMed ID: 12450381
[TBL] [Abstract][Full Text] [Related]
29. The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.
Mercurio FA; Di Natale C; Pirone L; Iannitti R; Marasco D; Pedone EM; Palumbo R; Leone M
Sci Rep; 2017 Dec; 7(1):17474. PubMed ID: 29234063
[TBL] [Abstract][Full Text] [Related]
30. Alternative modes of tyrosyl phosphopeptide binding to a Src family SH2 domain: implications for regulation of tyrosine kinase activity.
Ladbury JE; Hensmann M; Panayotou G; Campbell ID
Biochemistry; 1996 Aug; 35(34):11062-9. PubMed ID: 8780508
[TBL] [Abstract][Full Text] [Related]
31. SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.
De Schutter J; Guillabert A; Imbault V; Degraef C; Erneux C; Communi D; Pirson I
J Biol Chem; 2009 Dec; 284(52):36062-36076. PubMed ID: 19880507
[TBL] [Abstract][Full Text] [Related]
32. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
Qin C; Wavreille AS; Pei D
Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
[TBL] [Abstract][Full Text] [Related]
33. Calorimetric examination of high-affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics.
Bradshaw JM; Waksman G
Biochemistry; 1999 Apr; 38(16):5147-54. PubMed ID: 10213620
[TBL] [Abstract][Full Text] [Related]
34. Insights into structure and function of SHIP2-SH2: homology modeling, docking, and molecular dynamics study.
Saqib U; Siddiqi MI
J Chem Biol; 2011 Oct; 4(4):149-58. PubMed ID: 22328908
[TBL] [Abstract][Full Text] [Related]
35. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
[TBL] [Abstract][Full Text] [Related]
36. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
Blero D; De Smedt F; Pesesse X; Paternotte N; Moreau C; Payrastre B; Erneux C
Biochem Biophys Res Commun; 2001 Apr; 282(3):839-43. PubMed ID: 11401540
[TBL] [Abstract][Full Text] [Related]
37. Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome.
Leung KK; Hause RJ; Barkinge JL; Ciaccio MF; Chuu CP; Jones RB
Mol Cell Proteomics; 2014 Jul; 13(7):1705-23. PubMed ID: 24728074
[TBL] [Abstract][Full Text] [Related]
38. Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis.
Stefan M; Koch A; Mancini A; Mohr A; Weidner KM; Niemann H; Tamura T
J Biol Chem; 2001 Feb; 276(5):3017-23. PubMed ID: 11069926
[TBL] [Abstract][Full Text] [Related]
39. The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading.
Koch A; Mancini A; El Bounkari O; Tamura T
Oncogene; 2005 May; 24(21):3436-47. PubMed ID: 15735664
[TBL] [Abstract][Full Text] [Related]
40. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
